AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn how the wash sale rule impacts dividend ETFs in 2024 and what it means for your taxable gains. This quick intro covers key considerations and practical implications for DIY investors.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A looming major social security deadline could reshape retirement planning. This article explains what it is, why it ...
Analysts see a constructive Alphabet stock price prediction as cloud momentum and AI investments gain traction. The f...
Costco reports stronger quarterly results as its $250 billion expansion strategy accelerates, supported by a robust m...
For the first time ever, Citi Wealth notes a surge in ultrawealthy U.S. clients seeking cross-border diversification ...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...
Washington asserts that existing tariff pacts stay in force even after a Supreme Court setback. The stance draws mixe...
A 52-year-old investor with a $7.8 million net worth faces a pivotal choice: retire early or work a few more years to...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Ulta Beauty shares have tumbled in the wake of earnings, but analysts see a potential entry point. The ulta beauty pr...
A Buenos Aires court ordered a countrywide block on Polymarket after ruling it operated as an unlicensed betting serv...